title: Olanzapine versus risperidone: weight gain and elevation of serum triglyceride levels.
authors: The B' University Department of Psychiatry, Aristotelian University of Thessaloniki, and Community Mental Health Center, 20 Papadopoulou Str-Sikies, 56625 Thessaloniki, Greece. anakar@med.auth.gr
authors: George
authors: G
authors: Garyfallos
authors: Dimos
authors: D
authors: Dimelis
authors: Philippos
authors: P
authors: Kouniakis
authors: Nikos
authors: N
authors: Sidiropoulos
authors: Anastasia
authors: A
authors: Karastergiou
authors: Grigoris
authors: G
authors: Lavrentiadis
authors: John
authors: J
authors: Giouzepas
authors: Kostas
authors: K
authors: Fokas
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines / Q000009:adverse effects* / Q000627:therapeutic use; D015992:Body Mass Index; D002784:Cholesterol / Q000097:blood; D015331:Cohort Studies; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D000077152:Olanzapine; D011569:Psychiatric Status Rating Scales; D011618:Psychotic Disorders / Q000097:blood / Q000188:drug therapy*; D018967:Risperidone / Q000009:adverse effects* / Q000627:therapeutic use; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy*; D014280:Triglycerides / Q000097:blood*; D015430:Weight Gain / Q000187:drug effects*
chemical_list: D014150:Antipsychotic Agents; D014280:Triglycerides; D001569:Benzodiazepines; D002784:Cholesterol; D018967:Risperidone; D000077152:Olanzapine